IL-1 Inhibition and Function of the HDL-Containing Fraction of Plasma in Patients with Stages 3 to 5 CKD.
Clin J Am Soc Nephrol
; 14(5): 702-711, 2019 05 07.
Article
en En
| MEDLINE
| ID: mdl-31015261
Palabras clave
Anti-Inflammatory Agents; CKD; Cardiovascular Diseases; Cholesterol; Chronic inflammation; HDL; IL-1 inhibition; IL1RN protein, human; IL6 protein, human; Inflammation; Interleukin 1 Receptor Antagonist Protein; Lipoproteins, HDL; Macrophages, Peritoneal; NLR Proteins; Oxidants; Receptors, Interleukin-1; Renal Insufficiency, Chronic; Superoxides; Tumor Necrosis Factor-alpha; dialysis; macrophages; oxidative stress
Texto completo:
1
Colección:
01-internacional
Base de datos:
MEDLINE
Asunto principal:
Interleucina-1
/
Insuficiencia Renal Crónica
/
Lipoproteínas HDL
Tipo de estudio:
Clinical_trials
Límite:
Adult
/
Aged
/
Female
/
Humans
/
Male
/
Middle aged
Idioma:
En
Revista:
Clin J Am Soc Nephrol
Asunto de la revista:
NEFROLOGIA
Año:
2019
Tipo del documento:
Article